RE: All quiet on the Western Front9 Jul 2015 12:06
If I'd been making sandcastles for the length of time I've held these shares, there'd be no sand left on the beach!
IMHO I think the future (long term) prospects depend very much on any growth in sales of Varithena in the US, which is far from certain at present. Foam sclerotherapy is not an established therapy in America (yet) and it has to compete with some proven and effective modern minimally invasive techniques such as laser treatment and radiofrequency ablation. It's going to be a while yet before we know whether Varithena can gain a foothold over there.
I've come this far so I'm sticking with it, for now.